Skip to main content
. 2022 Nov 21;9:971762. doi: 10.3389/fcvm.2022.971762

FIGURE 1.

FIGURE 1

TAVI: A 20-year journey of transformative evolution from high-risk inoperable patients to the most recent European and US guidelines and low-risk younger patients along with landmark trials.